Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeOur CompanyOur societal impact Global Health Equity No more epidemics
      hqdefault.jpg

      No more epidemics

      Dr. Johan Van Hoof, Global Head of Janssen Vaccines, sat down for an on-camera interview with The Business Debate that has been posted on The Wall Street Journal. He spoke about Johnson & Johnson’s commitment to combat Ebola through Janssen’s vaccine development program, global partnerships and broader activities to promote pandemic preparedness.

      Share Article
      share to
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.